ADMA Biologics Inc

NASDAQ: ADMAHealthcare / Biotechnology / USA
4.0600.00Vol 725 2131Y Perf -28.50%
Aug 21st, 2019 16:00
BID4.00 ASK4.14
Open4.10 Previous Close4.06
Pre-Market4.25 After-Trading4.15
 0.19 4.68%  0.09 2.22%
Target Price
10.25 
Analyst Rating
Strong Buy 1.50
Potencial %
152.46 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★     43.81
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)241 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
40.57 
Earnings Date
9th Aug 2019

Today's Price Range

3.944.15

52wk Range

2.086.96

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
4.10%
1 Month
8.85%
3 Months
-13.62%
6 Months
-6.67%
1 Year
-28.50%
3 Years
-28.52%
5 Years
-57.26%
10 Years
-

Name / TickerPriceChg.Chg.%
ADMA4.060.00000.00
AAPL212.642.28001.08
GOOG1 191.258.56000.72
MSFT138.791.53001.11
XOM69.720.69001.00
WFC45.000.32000.72
JNJ131.530.93000.71
FB183.55-0.2600-0.14
GE8.16-0.2200-2.63
JPM107.610.30000.28
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.26-0.253.85
Q01 2019-0.32-0.313.12
Q04 2018-0.33-0.39-18.18
Q03 2018-0.33-0.330.00
Q02 2018-0.32-0.35-9.38
Q01 2018-0.27-0.35-29.63
Q04 2017-0.51-0.2452.94
Q03 2017-0.510.59215.69
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.2233.33Positive
12/2019 QR-0.1840.00Positive
12/2019 FY-0.9626.72Positive
12/2020 FY-0.5125.00Positive
Next Report Date-
Estimated EPS Next Report-0.26
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume725 213
Shares Outstanding (in ths.)59 317
Trades Count1 482
Dollar Volume1 250 332
Avg. Volume912 006
Avg. Weekly Volume566 475
Avg. Monthly Volume554 279
Avg. Quarterly Volume795 156
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (66.67 %)
5 (83.33 %)
3 (75.00 %)
Moderate Buy
1 (16.67 %)
1 (16.67 %)
1 (25.00 %)
Hold
1 (16.67 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.17
Strong Buy
1.25

ADMA Biologics Inc

ADMA Biologics Inc is a United States-based biopharmaceutical company. It is engaged in the manufacture, marketing and development of specialty plasma-derived biologics. The operating segments of the company are ADMA BioManufacturing segment; Plasma Collection Centers segment; and Corporate segment. The Plasma Collection Centers segment consists of three FDA-licensed source plasma collection facilities located in Georgia. The company's ADMA BioManufacturing segment reflects the company's immune globulin manufacturing and development operations in Florida. It derives a majority of the revenue from the Plasma Collection Centers.

CEO: Adam S. Grossman

Teplephone: +1 201 478-5552

Address: 465 State Route 17, Ramsey 07446, NJ, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

55%45%

News